Banking Crisis Prompts Postponed Noile-Immune IPO, But Wider Japan Views Mixed

 
• By Lisa Takagi
  
Although not fearing the direct impact from the global banking crisis, Japan’s biotech/bioventure market in in a cautious for its potential impact.
Although not fearing the direct impact from the global banking crisis, Japan’s biotech/bioventure market is in a cautious for its potential impact. • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Japan

More from Focus On Asia